Skip to main content
BioCentury on BioBusiness
Feature Story

Cover Story: Product Development: Would you rather?

How patient preference data make patient engagement real

By Steve Usdin, Washington Editor

Medical product developers, regulators and patients are starting to apply social science to life science, using techniques created to measure the preferences of individuals and groups to shape how medicines are designed, tested, regulated and used.

The integration of quantitative, testable methods for determining preferences into medical product development is being driven by the realization that reorienting the entire healthcare system to focus on the patients it serves is the best way to remove roadblocks to innovation.

Read Article

Today's Biotech & Pharma News

  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial